The company will be participating in a one-to-one meeting with investors, scheduled as a physical meeting in Mumbai.
The meeting is scheduled for September 24, 2026. The specific time was not disclosed in the announcement.
The stated purpose of the event is investor interaction, though no specific discussion topics (such as quarterly results) were mentioned.
The announcement does not specify if this meeting is scheduled before or after an earnings announcement.
Management participants and their designations were not provided in this disclosure.
The company indicated that relevant press releases and investor presentations proposed to be discussed are available on the company's website (www.fermentabiotech.com) and stock exchange websites.
The company explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions.
Additional Notes Section
The disclosure was made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company noted that changes to the meeting schedule may occur due to exigencies on the part of the company or investors.
No financial data, performance figures, or strategic updates were disclosed in this announcement.
The document was digitally signed by Varadvinayak Vijay Khambete, Company Secretary & Head - Legal (Membership No. A33861).
